Burden of DR-TB in India
H5ContentTypes of Drug Resistance Tuberculosis -DRTB
H5ContentHistory of Programmatic Management of Drug Resistant TB [PMDT] in India
H5ContentNewer Anti-TB Drugs
H5ContentNewer Anti-TB Drugs: Pretomanid [Pa]
H5ContentWHO recommendation for newer, shorter, oral regimens
H5ContentBPaLM regimen for DR-TB
H5ContentEvidence for the efficacy of BPaL regimen in DR-TB
H5ContentRationale for continuation of Moxifloxacin in BPaLM regimen irrespective of FQ resistance
H5ContentShorter oral Bedaquiline-containing MDR/RR-TB regimen
H5Content2024 NTEG Recommendations for DR-TB Management
H5Content2024 Updates in DR-TB Management
H5Content
Cover
This is a overview chapter on PMDT. it discusses various evidence available for newer DR-TB regimens, the rationale for using the combination and brief overview about the newer drugs.